Mindfulness meditation: impact on attentional control and emotion dysregulation
RS Prakash - Archives of Clinical Neuropsychology, 2021 - academic.oup.com
Objective Theoretical models of mindfulness meditation conceptualize the cultivation of
focused attention and regulation of emotional states, with the attitudinal foundations that …
focused attention and regulation of emotional states, with the attitudinal foundations that …
[HTML][HTML] Lower extremity muscle power–A critical determinant of physical function in aging and multiple sclerosis
RAW Stagsted, C Ramari, AG Skjerbaek, C Thrue… - Experimental …, 2021 - Elsevier
Background and purpose In aging, lower extremity muscle power is undoubtedly one of the
most important parameters of neuromuscular function implicating lower extremity physical …
most important parameters of neuromuscular function implicating lower extremity physical …
[HTML][HTML] Multiple sclerosis following SARS-CoV-2 infection: a case report and literature review
S Sarwar, S Rogers, AS Mohamed, E Ogula… - Cureus, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory
coronavirus 2 (SARS-CoV-2). Apart from respiratory manifestations, COVID-19 can affect the …
coronavirus 2 (SARS-CoV-2). Apart from respiratory manifestations, COVID-19 can affect the …
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
Y Zhang, N Gonzalez Caldito… - Therapeutic …, 2020 - journals.sagepub.com
Background: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved
for the treatment of disease activity and are effective in reducing relapses and new magnetic …
for the treatment of disease activity and are effective in reducing relapses and new magnetic …
Initiation patterns of disease-modifying therapies for multiple sclerosis among US adults and children, 2001 through 2020
M Henderson, DB Horton, V Bhise, G Pal… - JAMA …, 2023 - jamanetwork.com
Importance Many disease-modifying therapies (DMTs) have been approved for multiple
sclerosis (MS) in the past 2 decades. Research evaluating how these approvals have …
sclerosis (MS) in the past 2 decades. Research evaluating how these approvals have …
Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions
Objective Multiple sclerosis (MS) lesions are heterogeneous with regard to inflammation,
demyelination, axonal injury, and neuronal loss. We previously developed a diffusion basis …
demyelination, axonal injury, and neuronal loss. We previously developed a diffusion basis …
Classification criteria for multiple sclerosis-associated intermediate uveitis
… of Uveitis Nomenclature (SUN) Working Group - American journal of …, 2021 - Elsevier
Purpose The purpose of this study was to determine classification criteria for multiple
sclerosis-associated intermediate uveitis. Design Machine learning of cases with multiple …
sclerosis-associated intermediate uveitis. Design Machine learning of cases with multiple …
[HTML][HTML] The role of antibodies in the pathogenesis of multiple sclerosis
X Yu, M Graner, PGE Kennedy, Y Liu - Frontiers in neurology, 2020 - frontiersin.org
The presence of persistent intrathecal oligoclonal immunoglobulin G (IgG) bands (OCBs)
and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease …
and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease …
Automated detection of real-world falls: Modeled from people with multiple sclerosis
Falls are a major health problem with one in three people over the age of 65 falling each
year, oftentimes causing hip fractures, disability, reduced mobility, hospitalization and death …
year, oftentimes causing hip fractures, disability, reduced mobility, hospitalization and death …
Effectiveness of ocrelizumab in primary progressive multiple sclerosis: a multicenter, retrospective, real-world study (OPPORTUNITY)
Ocrelizumab is a recombinant humanized monoclonal antibody selectively targeting CD20-
expressing B cells. The effect of ocrelizumab on primary progressive multiple sclerosis …
expressing B cells. The effect of ocrelizumab on primary progressive multiple sclerosis …